new TOP 200 Companies filing patents this week

new Companies with the Most Patent Filings (2010+)





Similar
Filing Names

Actavis Group Ptc Ehf
Actavis Group Ptc Ehf_20100107
  

Actavis Group Ptc Ehf patents

Recent patent applications related to Actavis Group Ptc Ehf. Actavis Group Ptc Ehf is listed as an Agent/Assignee. Note: Actavis Group Ptc Ehf may have other listings under different names/spellings. We're not affiliated with Actavis Group Ptc Ehf, we're just tracking patents.

ARCHIVE: New 2017 2016 2015 2014 2013 2012 2011 2010 2009 | Company Directory "A" | Actavis Group Ptc Ehf-related inventors




Date Actavis Group Ptc Ehf patents (updated weekly) - BOOKMARK this page
02/25/16Pemetrexed formulation
11/19/15Novel crystalline form of ticagrelor and process for the preparation thereof
10/22/15Solid state forms of tapentadol salts
07/24/14Process for preparing cyclopentylamine derivatives and intermediates thereof
01/02/14Process for preparing quinoline-3-carboxamide derivatives
11/28/13Novel processes for preparing triazolo[4, 5-d]pyrimidine derivatives and intermediates thereof
06/27/13Novel processes for the preparation of phenylcyclopropylamine derivatives and use thereof for preparing ticagrelor
06/13/13Novel process for preparing phenylcyclopropylamine derivatives using novel intermediates
04/25/13Highly pure varenicline or a pharmaceutically acceptable salt thereof substantially free of methylvarenicline impurity
04/18/13Resolution methods for isolating desired enantiomers of tapentadol intermediates and use thereof for the preparation of tapentadol
04/18/13Novel process for preparing highly pure tapentadol or a pharmaceutically acceptable salt thereof
04/11/13Solid state forms of tapentadol salts
03/21/13Process for preparing varenicline, varenicline intermediates, and pharmaceutically acceptable salts thereof
01/31/13Processes for preparing ticagrelor intermediate, 4,6-dichloro-5-nitro-2-(propylthio)pyrimidine
10/25/12Solid state forms of rasagiline salts
06/28/12Paliperidone or a pharmaceutically acceptable salt thereof substantially free of impurities
04/26/12Solid state forms of paliperidone salts and process for the preparation thereof
04/19/12Amorphous varenicline tartrate co-precipitates
03/01/12Purification process for preparing highly pure arformoterol tartrate substantially free of desformyl impurity
02/02/12Highly pure eletriptan or a pharmaceutically acceptable salt thereof substantially free of eletriptan n-oxide impurity
01/12/12Highly pure laquinimod or a pharmaceutically acceptable salt thereof
12/29/11Highly pure cinacalcet or a pharmaceutically acceptable salt thereof
12/22/11Processes for preparing highly pure rotigotine or a pharmaceutically acceptable salt thereof
12/22/11Processes for preparing substantially pure arformoterol and its intermediates
12/08/11Novel solid state forms of ranolazine salts
10/06/11Process for preparing pregabalin
09/15/11Highly pure ranolazine or a pharmaceutically acceptable salt thereof
09/15/11Process for preparing varenicline, varenicline intermediates, and pharmaceutically acceptable salts thereof
07/21/11Unsaturated cinacalcet salts and processes for preparing cinacalcet hydrochloride
07/14/11Substantially pure deferasirox and processes for the preparation thereof
07/14/11Novel solid state forms of laquinimod and its sodium salt
07/14/11Fesoterodine substantially free of dehydroxy impurity
06/16/11Amorphous coprecipitates of atorvastatin pharmaceutically acceptable salts
05/26/11Solid state forms of fesoterodine intermediates
05/19/11Rasagiline mesylate particles and process for the preparation thereof
05/05/11Process for preparing quinoline-3-carboxamide derivatives
04/28/11Solid state forms of deferasirox salts and process for the preparation thereof
04/14/11Novel mandelate salt of fesoterodine
03/24/11Solid state forms of tapentadol salts
02/24/11Solid forms of (±)-o-desmethylvenlafaxine salts
01/27/11Substantially pure and a stable crystalline form of bosentan
01/20/11Amorphous arformoterol l-(+)-tartrate
01/20/11Novel polymorphs of bosentan
12/30/10Substantially pure imatinib or a pharmaceutically acceptable salt thereof
12/16/10Process for the preparation of risedronate sodium
11/25/10Amorphous fesoterodine fumarate
11/11/10Novel hemioxalate salt of eletriptan
11/04/10Quetiapine salts and their polymorphs
10/28/10Amorphous form of tapentadol hydrochloride
10/14/10Novel polymorph of atorvastatin calcium and use thereof for the preparation of amorphous atorvastatin calcium
08/26/10Process for the preparation of fesoterodine
08/12/10Novel polymorphs of darifenacin free base and its hydrobromide salt
08/05/10Repaglinide substantially free of dimer impurity
07/08/10Process for the preparation of alfuzosin and salts thereof
06/17/10Stable atorvastatin formulations
04/29/10Lercanidipine hydrochloride polymorphs and an improved process for preparation of 1,1,n-trimethyl-n-(3,3-diphenylpropyl)-2-aminoethyl acetoacetate
01/07/10Process for preparation of 9-hydroxy-3-(2-chloroethyl)-2-methyl-4h-pyrido[1,2-a]pyrimidin-4-one hydrochloride
10/01/09O-desmethylvenlafaxine cocrystals
10/01/09Highly pure paliperidone or a pharmaceutically acceptable salt thereof substantially free of keto impurity
07/30/09Controlled-release tolterodine compositions and methods
07/16/09Anhydrous amorphous imatinib mesylate
03/05/09Paliperidone polymorphs
01/07/10Process for preparation of 9-hydroxy-3-(2-chloroethyl)-2-methyl-4h-pyrido[1,2-a]pyrimidin-4-one hydrochloride







ARCHIVE: New 2017 2016 2015 2014 2013 2012 2011 2010 2009



###

This listing is an abstract for educational and research purposes is only meant as a recent sample of applications filed, not a comprehensive history. Freshpatents.com is not affiliated or associated with Actavis Group Ptc Ehf in any way and there may be associated servicemarks. This data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for Actavis Group Ptc Ehf with additional patents listed. Browse our Agent directory for other possible listings. Page by FreshPatents.com

###




';